LONG-TERM OUTCOMES IN RHEUMATOID ARTHRITIS IN RELATION TO THE TIME AFTER THE INITIATIONOF BASIC ANTI-INFLAMMATORY DRUG THERAPY

The paper presents the long-term outcomes of rheumatoid arthritis (RA) according to the data of a 15-year prospective follow-up and treatment in 240 patients with the disease. Disease activity resistance (stable remission of more than 2 years, a recurring course with druginduced remissions of 6-18 m...

Full description

Saved in:
Bibliographic Details
Main Authors: Natalya Vladimirovna Chichasova, M Z Kanevskaya, G R Imametdinova, E V Igolkina, E L Nasonov
Format: Article
Language:Russian
Published: IMA PRESS LLC 2010-06-01
Series:Научно-практическая ревматология
Subjects:
Online Access:https://rsp.mediar-press.net/rsp/article/view/577
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849688950254338048
author Natalya Vladimirovna Chichasova
M Z Kanevskaya
G R Imametdinova
E V Igolkina
E L Nasonov
author_facet Natalya Vladimirovna Chichasova
M Z Kanevskaya
G R Imametdinova
E V Igolkina
E L Nasonov
author_sort Natalya Vladimirovna Chichasova
collection DOAJ
description The paper presents the long-term outcomes of rheumatoid arthritis (RA) according to the data of a 15-year prospective follow-up and treatment in 240 patients with the disease. Disease activity resistance (stable remission of more than 2 years, a recurring course with druginduced remissions of 6-18 months, or no remissions), the degree of joint destruction progression, the functional state of patients and their survival were assessed in relation to the time of use of basic anti-inflammatory drugs (BAIDs). In groups 1, 2, and 3, BAID therapy was initiated within the first 5 months of RA, 6-11 and 12-36 months after its onset, respectively. The treatment was monitored, by estimating clinical and X-ray parameters, the functional state of the locomotor apparatus and by correcting the therapy at its stages in the absence of reliable suppression of RA activity and/or with the continuing emergence of new erosions in small joints. The early use of BAIDs under meticulous control of the degree of RA activity suppression and RA progression were shown to frequently achieve clinical and laboratory remissions and to improve functional and life prognosis in the patients.
format Article
id doaj-art-dd1b38f03af94b61ace27fb9e0145daa
institution DOAJ
issn 1995-4484
1995-4492
language Russian
publishDate 2010-06-01
publisher IMA PRESS LLC
record_format Article
series Научно-практическая ревматология
spelling doaj-art-dd1b38f03af94b61ace27fb9e0145daa2025-08-20T03:21:47ZrusIMA PRESS LLCНаучно-практическая ревматология1995-44841995-44922010-06-01483233010.14412/1995-4484-2010-439517LONG-TERM OUTCOMES IN RHEUMATOID ARTHRITIS IN RELATION TO THE TIME AFTER THE INITIATIONOF BASIC ANTI-INFLAMMATORY DRUG THERAPYNatalya Vladimirovna ChichasovaM Z KanevskayaG R ImametdinovaE V IgolkinaE L NasonovThe paper presents the long-term outcomes of rheumatoid arthritis (RA) according to the data of a 15-year prospective follow-up and treatment in 240 patients with the disease. Disease activity resistance (stable remission of more than 2 years, a recurring course with druginduced remissions of 6-18 months, or no remissions), the degree of joint destruction progression, the functional state of patients and their survival were assessed in relation to the time of use of basic anti-inflammatory drugs (BAIDs). In groups 1, 2, and 3, BAID therapy was initiated within the first 5 months of RA, 6-11 and 12-36 months after its onset, respectively. The treatment was monitored, by estimating clinical and X-ray parameters, the functional state of the locomotor apparatus and by correcting the therapy at its stages in the absence of reliable suppression of RA activity and/or with the continuing emergence of new erosions in small joints. The early use of BAIDs under meticulous control of the degree of RA activity suppression and RA progression were shown to frequently achieve clinical and laboratory remissions and to improve functional and life prognosis in the patients.https://rsp.mediar-press.net/rsp/article/view/577rheumatoid arthritisbasic anti-inflammatory drugsremissionmonitoring
spellingShingle Natalya Vladimirovna Chichasova
M Z Kanevskaya
G R Imametdinova
E V Igolkina
E L Nasonov
LONG-TERM OUTCOMES IN RHEUMATOID ARTHRITIS IN RELATION TO THE TIME AFTER THE INITIATIONOF BASIC ANTI-INFLAMMATORY DRUG THERAPY
Научно-практическая ревматология
rheumatoid arthritis
basic anti-inflammatory drugs
remission
monitoring
title LONG-TERM OUTCOMES IN RHEUMATOID ARTHRITIS IN RELATION TO THE TIME AFTER THE INITIATIONOF BASIC ANTI-INFLAMMATORY DRUG THERAPY
title_full LONG-TERM OUTCOMES IN RHEUMATOID ARTHRITIS IN RELATION TO THE TIME AFTER THE INITIATIONOF BASIC ANTI-INFLAMMATORY DRUG THERAPY
title_fullStr LONG-TERM OUTCOMES IN RHEUMATOID ARTHRITIS IN RELATION TO THE TIME AFTER THE INITIATIONOF BASIC ANTI-INFLAMMATORY DRUG THERAPY
title_full_unstemmed LONG-TERM OUTCOMES IN RHEUMATOID ARTHRITIS IN RELATION TO THE TIME AFTER THE INITIATIONOF BASIC ANTI-INFLAMMATORY DRUG THERAPY
title_short LONG-TERM OUTCOMES IN RHEUMATOID ARTHRITIS IN RELATION TO THE TIME AFTER THE INITIATIONOF BASIC ANTI-INFLAMMATORY DRUG THERAPY
title_sort long term outcomes in rheumatoid arthritis in relation to the time after the initiationof basic anti inflammatory drug therapy
topic rheumatoid arthritis
basic anti-inflammatory drugs
remission
monitoring
url https://rsp.mediar-press.net/rsp/article/view/577
work_keys_str_mv AT natalyavladimirovnachichasova longtermoutcomesinrheumatoidarthritisinrelationtothetimeaftertheinitiationofbasicantiinflammatorydrugtherapy
AT mzkanevskaya longtermoutcomesinrheumatoidarthritisinrelationtothetimeaftertheinitiationofbasicantiinflammatorydrugtherapy
AT grimametdinova longtermoutcomesinrheumatoidarthritisinrelationtothetimeaftertheinitiationofbasicantiinflammatorydrugtherapy
AT evigolkina longtermoutcomesinrheumatoidarthritisinrelationtothetimeaftertheinitiationofbasicantiinflammatorydrugtherapy
AT elnasonov longtermoutcomesinrheumatoidarthritisinrelationtothetimeaftertheinitiationofbasicantiinflammatorydrugtherapy